Tanvex BioPharma Inc
6541StockTW
39.45 ▲ +2.73%
12 juin 2026
6
Tanvex BioPharma Inc
39.45 ▲ +2.73%
12 juin 2026
6541StockTW

01 / À propos

Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.

Arberion
Loading market data